HRTX(HRTX)
HRTX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $166M | $176M | $202M | $240M | $269M |
| Low | $154M | $163M | $171M | $222M | $249M |
| High | $178M | $189M | $233M | $257M | $289M |
| EBITDA Avg | $-98M | $-104M | $-120M | $-142M | $-160M |
| Low | $-105M | $-112M | $-139M | $-153M | $-171M |
| High | $-91M | $-97M | $-101M | $-132M | $-148M |
| EBIT Avg | $-100M | $-106M | $-122M | $-145M | $-163M |
| Low | $-107M | $-114M | $-141M | $-155M | $-174M |
| High | $-93M | $-99M | $-103M | $-134M | $-151M |
| Net Income Avg | $-11M | $-2M | $15M | $29M | $41M |
| Low | $-12M | $-2M | $10M | $26M | $37M |
| High | $-10M | $-2M | $20M | $32M | $45M |
| EPS Avg | $-0.07 | $-0.01 | $0.09 | $0.17 | $0.24 |
| Low | $-0.07 | $-0.01 | $0.06 | $0.16 | $0.22 |
| High | $-0.06 | $-0.01 | $0.12 | $0.19 | $0.27 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $42M | $47M |
| Low | $41M | $46M |
| High | $43M | $48M |
| EBITDA Avg | $-25M | $-28M |
| Low | $-25M | $-28M |
| High | $-25M | $-27M |
| EBIT Avg | $-25M | $-28M |
| Low | $-26M | $-29M |
| High | $-25M | $-28M |
| Net Income Avg | $-2M | $-2M |
| Low | $-2M | $-2M |
| High | $-2M | $-2M |
| EPS Avg | $-0.01 | $-0.01 |
| Low | $-0.01 | $-0.01 |
| High | $-0.01 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |